{"database": "lobbying", "table": "lobbying_activities", "rows": [[1733590, "50d58cc8-6b91-4402-9033-a5f6606e9d89", "Q3", "RED+BLUE STRATEGIES", 400693064, "COHERUS BIOSCIENCES", 2015, "third_quarter", "PHA", "CMS Proposed Physician Fee Schedule(PFS) with a focus on provisions dealthing with the treatment of Medicare's reimbursement for a new class of prescription medications, Biosimilars. \n\nEducation and advocacy related to what elements are necessary to ensure a hospitable environment to grow the new Biosimilars market in the United States.", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 20000, null, 0, 0, "2015-10-16T11:32:18.847000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1733590"], "units": {}, "query_ms": 2.610884024761617, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}